PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

DANA-FARBER CANCER INSTITUTE, INC.

USPTO PatentsView assignee record — 716 granted patents across 49 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Explore the portfolio See the ranking
716
Total patents granted
49
CPC technology areas
19.2
Avg claims per patent
+65%
5-year filing velocity

Portfolio overview

DANA-FARBER CANCER INSTITUTE, INC. has been granted 716 US utility patents between 2015 and 2025, placing DANA-FARBER CANCER INSTITUTE, INC. at rank #616 across all assignees tracked by PlainPatent. This portfolio spans 49 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, DANA-FARBER CANCER INSTITUTE, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 64.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 446 grants, compared with 270 in the 2015–2019 window — a +65% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. DANA-FARBER CANCER INSTITUTE, INC.'s 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 49 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark DANA-FARBER CANCER INSTITUTE, INC. against peers pursuing similar technology classes.

How does DANA-FARBER compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows DANA-FARBER holds 716 patents — placing it at rank #616 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 58
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
DANA-FARBER CANCER INSTITUTE, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 35 4.9%
2016 39 5.4%
2017 60 8.4%
2018 62 8.7%
2019 74 10.3%
2020 97 13.5%
2021 82 11.5%
2022 76 10.6%
2023 62 8.7%
2024 71 9.9%
2025 58 8.1%

Which technologies does DANA-FARBER CANCER INSTITUTE, INC. patent most?

Top 15 of 49 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#616

Across all tracked assignees

Innovation Score

64.5 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does DANA-FARBER CANCER INSTITUTE, INC. hold?
DANA-FARBER CANCER INSTITUTE, INC. holds 716 US granted patents filed between 2015 and 2025, spanning 49 technology areas.
What is DANA-FARBER CANCER INSTITUTE, INC.'s Innovation Score?
DANA-FARBER CANCER INSTITUTE, INC. has an Innovation Score of 64.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does DANA-FARBER CANCER INSTITUTE, INC. focus on?
DANA-FARBER CANCER INSTITUTE, INC.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 493 patents. The company has filed patents in 49 CPC subclasses total.
Is DANA-FARBER CANCER INSTITUTE, INC.'s patent filing rate increasing or decreasing?
DANA-FARBER CANCER INSTITUTE, INC.'s recent filing velocity is +65% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for DANA-FARBER CANCER INSTITUTE, INC.'s patents?
DANA-FARBER CANCER INSTITUTE, INC.'s patents average 19.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the DANA-FARBER CANCER INSTITUTE, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61P technology

DANA-FARBER CANCER INSTITUTE, INC.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where DANA-FARBER CANCER INSTITUTE, INC. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope